Hypocretin (Orexin) regulates glutamate input to fast-spiking interneurons in layer v of the Fr2 region of the murine prefrontal cortex

Cerebral Cortex

Volumn 25, Issue 5, 2015, Pages 1330-1347

  Aracri, Patrizia ^a   Banfi, Daniele ^a   Pasini, Maria Enrica ^b   Amadeo, Alida ^b   Becchetti, Andrea ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Fast spiking; HCRTR; OXR1; Premotor; SB 334867; VGLUT

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; GLUTAMIC ACID; OREXIN; OREXIN 1 RECEPTOR; OREXIN A; TETRODOTOXIN; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; BENZOXAZOLE DERIVATIVE; IONOTROPIC RECEPTOR; OREXIN RECEPTOR; OREXIN RECEPTOR ANTAGONIST; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; BRAIN SLICE; EXCITATORY POSTSYNAPTIC POTENTIAL; EXECUTIVE FUNCTION; FAST SPIKING INTERNEURON; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MOTIVATION; MOUSE; NERVE CELL; NONHUMAN; PATCH CLAMP TECHNIQUE; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; ELECTROPHYSIOLOGY; INBRED MOUSE STRAIN; METABOLISM; NERVE CELL INHIBITION; PHYSIOLOGY; PROCEDURES; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUE;

ANIMALS; BENZOXAZOLES; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; INTERNEURONS; MICE; MICE, INBRED STRAINS; NEURAL INHIBITION; OREXIN RECEPTOR ANTAGONISTS; OREXIN RECEPTORS; OREXINS; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RECEPTORS, IONOTROPIC GLUTAMATE; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUES; UREA; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 84928911794     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bht326     Document Type: Article

References (94)

1. Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L. 2007. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature. 450:420-424.
2. Ammoun S, Holmqvist T, Shariatmadari R, Oonk HB, Detheux M, Par-mentier M, Akerman KE, Kukkonen JP. 2003. Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharmacol Exp Ther. 305:507-514.
3. Aracri P, Amadeo A, Pasini ME, Fascio U, Becchetti A. 2013. Regulation of glutamate release by heteromeric nicotinic receptors in layer V of the secondary motor region (Fr2) in the dorsomedial shoulder of prefrontal cortex in mouse. Synapse. 67:338-357.
4. Aracri P, Consonni S, Morini R, Perrella M, Rodighiero S, Amadeo A, Becchetti A. 2010. Tonic modulation of GABA release by nicotinic acetylcholine receptors, in layer V of the murine prefrontal cortex. Cereb Cortex. 20:1539-1555.
5. Bacci A, Rudolph U, Huguenard JR, Prince DA. 2003. Major differences in inhibitory synaptic transmission onto two neocortical inter-neuron subclasses. J Neurosci. 23:9664-9674.
6. Baldo BA, Daniel RA, Berridge CW, Kelley AE. 2003. Overlapping distributions of orexin/hypocretin-and dopamine-p-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol. 464:220-237.
7. Bayer L, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Miihlefha-ler M, Serafin M. 2002. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J Neurosci. 22:7835-7839.
8. Bayer L, Eggermann E, Serafin M, Saint-Mleux B, Machard D, Jones B, Miihlethaler M. 2001. Orexins (hypocretins) directly excite tubero-mammillary neurons. Eur J Neurosci. 14:1571-1575.
9. Bayer L, Serafin M, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Miihlethaler M. 2004. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci. 24:6760-6764.
10. Berendsee HW, Galis-de Graaf Y, Groenewegen HJ. 1992. Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol. 316:314-347.
11. Beuckmann CT, Yanagisawa M. 2002. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med. 80:329-342.
12. Boutrel B, Cannella N, de Lecea L. 2010. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res. 1314:103-111.
13. Burdakov D, Liss B, Ashcroft FM. 2003. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger. J Neurosci. 23:4951-4957.
14. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y et al. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:437-451.
15. Clancy B, Cauller LJ. 1999. Widespread projections from subgriseal neurons (layer VII) to layer I in adult rat cortex. J Comp Neurol. 407:275-286.
16. Conde F, Maire-Lepoivre E, Audinat E, Crepel F. 1995. Afferent connections of the medial frontal cortex of the rat. II. Cortical and subcortical afferents. J Comp Neurol. 352:567-593.
17. Connors BW, Gutnick MJ. 1990. Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci. 13:99-104.
18. Couey JJ, Meredith RM, Spijker S, Poorthuis RB, Smit AB, Brussaard AB, Mansvelder HD. 2007. Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron. 54:73-87.
19. Cutler DJ, Morris R, Sheridhar V, Wattam TA, Holmes S, Patel S, Arch JR, Wilson S, Buckingham RE, Evans ML et al. 1999. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides. 20:1455-1470.
20. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, Nakazato M. 1999. Orexins, orexi-genic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA. 96:748-753.
21. del Cid-Pellitero E, Garzon M. 2011. Hypocretinl/OrexinA axon targeting of laterodorsal tegmental nucleus neurons projecting to the rat medial prefrontal cortex. Cereb Cortex. 21:2762-2773.
22. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fuku-hara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd et al. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 95:322-327.
23. Douglas RJ, Martin KAC. 2004. Neuronal circuits of the neocortex. Annu Rev Neurosci. 27:419-451.
24. Eggermann E, Serafin M, Bayer L, Machard D, Saint-Mleux B, Jones BE, Miihlethaler M. 2001. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience. 108:177-181.
25. Eriksson KS, Sergeeva O, Brown RE, Haas HL. 2001. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci. 21:9273-9279.
26. Fadel J, Deutch AY. 2002. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience. 111:379-387.
27. Fadel J, Pasumarthi R, Reznikov LR. 2005. Stimulation of cortical acetylcholine release by orexin A. Neuroscience. 130:541-547.
28. Franklin KJB, Chudasama Y 2011. The prefrontal cortex. In: Watson C, Paxinos G, Puelles L, editors. The mouse nervous system. Amsterdam (The Netherlands): Elsevier Academic Press, pp. 727-735.
29. Gerashchenko D, Bianco-Centurion C, Greco MA, Shiromani PJ. 2003.Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience. 116:223-235.
30. Gonchar Y, Wang Q, Burkhalter A. 2008. Multiple distinct subtypes of GABAergic neurons in mouse visual cortex identified by triple im-munostaining. Front Neuroanat. 1:3.
31. Graziano A, Liu XB, Murray KD, Jones EG. 2008. Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse. J Comp Neurol. 507:1258-1276.
32. Guan JL, Saotome T, Wang QP, Funahashi H, Hon T, Tanaka S, Shioda S. 2001. Orexinergic innervation of POMC-containing neurons in the rat arcuate nucleus. Neuroreport. 12:547-551.
33. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P et al. 1999. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA. 96:10911-10916.
34. Heidbreder CA, Groenewegen HJ. 2003. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev. 27:555-579.
35. Helmeke C, Ovtscharoff W Jr, Poeggel G, Braun K. 2008. Imbalance of immunohistochemically characterized interneuron populations in the adolescent and adult rodent medial prefrontal cortex after repeated exposure to neonatal separation stress. Neuroscience. 152:18-28.
36. Henny P, Brischoux F, Mainville L, Stroh T, Jones BE. 2010. Immuno-histochemical evidence for synaptic release of glutamate from orexin terminals in the locus coeruleus. Neuroscience. 169:1150-1157.
37. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA. 2001. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience. 103:777-797.
38. Holmqvist T, Akerman KE, Kukkonen JP. 2001. High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides. Neurosci Lett. 305:177-180.
39. Hoover WB, Vertes RP. 2007. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Fund. 212:149-179.
40. Horvath TL, Peyron C, Diano S, Ivanov A, Aston-Jones G, Kilduff TS, van den Pol AN. 1999. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol. 415:145-159.
41. Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O. 2001. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci USA. 98:9965-9970.
42. Hur EE, Zaborsky L. 2005. Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: a combined retrograde tracing in situ hybridization study. J Comp Neurol. 483:351-373.
43. Jones BE. 2008. Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems. Ann NY Acad Sci. 1129:26-34.
44. Kane JK, Tanaka H, Parker SL, Yanagisawa M, Li MD. 2000. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y and secretin. Biochem Biophys Res Commun. 272:959-965.
45. Kargo WJ, Szatmary B, Nitz DA. 2007. Adaptation of prefrontal cortical firing patterns and their fidelity to changes in action-reward contingencies. J Neurosci. 27:3548-3559.
46. Karnani MM, Apergis-Schoute J, Adamantidis A, Jensen LT, de Lecea L, Fugger L, Burdakov D. 2011. Activation of central orexin/hypocretin neurons by dietary amino acids. Neuron. 72:616-629.
47. Karteris E, Machado RJ, Chen J, Zervou S, Hillhouse EW, Randeva HS. 2005. Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex. Am J Physiol Endocrinol Metab. 288:E1089-E1100.
48. Kawaguchi Y, Kondo S. 2002. Parvalbumin, somatostatin and chole-cystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex. J Neurocytol. 31:277-287.
49. Kawaguchi Y, Kubota Y. 1997. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex. 7:476-486.
50. Kiritoshi T, Sun H, Ren W, Stauffer SR, Lindsley CW, Conn PJ, Neuge-bauer V. 2013. Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1. Neuropharmacology. 66:170-178.
51. Kirkcaldie MT, Dickson TC, King CE, Grasby D, Riederer BM, Vickens JC. 2002. Neurofilament triplet proteins are restricted to a subset of neurons in the rat neocortex. J Chem Neuroanat. 24:163-171.
52. Kohlmeier KA, Watanabe S, Tyler CJ, Burlet S, Leonard CS. 2008. Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J Neuro-physiol. 100:2265-2281.
53. Kubota Y, Shigematsu N, Karube F, Sekigawa A, Kato S, Yamaguchi N, Hirai Y, Morishima M, Kawaguchi Y. 2011. Selective coexpression of multiple chemical markers defines discrete populations of neo-cortical GABAergic neurons. Cereb Cortex. 21:1803-1817.
54. Kukkonen JP. 2013. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol. 304:C2-C32.
55. Lambe EK, Aghajanian GK. 2003. Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron. 40:139-150.
56. Lambe EK, Liu R-J, Aghajanian GK. 2007. Schizophrenia, hypocretin (orexin), and the thalamocortical activating system. Schizophrenia Bull. 33:1284-1290.
57. Lambe EK, Olausson P, Horst NK, Taylor JR, Aghajanian GK. 2005. Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. J Neurosci. 25:5225-5229.
58. Lee MG, Hassani OK, Jones BE. 2005. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci. 25:6716-6720.
59. Li B, Chen F, Ye J, Chen X, Yan J, Li Y, Xiong Y, Zhou Z, Xia J, Hu Z. 2010. The modulation of orexin A on HCN currents of pyramidal neurons in mouse prelimbic cortex. Cereb Cortex. 20:1756-1767.
60. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:365-376.
61. Liu RJ, Aghajanian GK. 2008. Stress blunts serotonin-and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendrite atrophy. Proc Natl Acad Sci USA. 105:359-364.
62. Liu RJ, van den Pol AN, Aghajanian GK. 2002. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci. 22:9453-9464.
63. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK. 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 435:6-25.
64. B receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc Natl Acad Sci USA. 106:4459-4464.
65. Mileykovskiy BY, Kiyashchenko LI, Siegel JM. 2005. Behavioral correlates of activity in identified orexin/hypocretin neurons. Neuron. 46:787-798.
66. Mishima K, Fujiki N, Yoshida Y, Sakurai T, Honda M, Mignot E, Nishino S. 2008. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy. Sleep. 31:1119-1126.
67. Nakamura K, Hioki H, Fujiyama F, Kaneko T. 2005. Postnatal changes of vesicular glutamate transporter (VGluT)l and VGluT2 immunoreactivities and their colocalization in the mouse forebrain. J Comp Neurol. 492:263-288.
68. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K. 1999. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:243-260.
69. Ohno K, Sakurai T. 2008. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol. 29:70-87.
70. Oishi Y, Williams RH, Agostinelli L, Arrigoni E, Fuller PM, Mochizuki T, Saper CB, Scammell TE. 2013. Role of the medial prefrontal cortex in cataplexy. J Neurosci. 33:9743-9751.
71. Palomero-Gallagher N, Zilles K. 2004. Isocortex. In: Paxinos G, editor. The rat nervous system. 3rd ed. Amsterdam (The Netherlands): Elsevier Academic Press, pp. 729-753.
72. Paulussen M, Jacobs S, Van der Gucht E, Hof PR, Arckens L. 2011. Cy-toarchitecture of the mouse neocortex revealed by the low-molecular-weight neurofilament protein subunit. Brain Struct Fund. 216:183-199.
73. Paxinos G, Franklin KBJ. 2001. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego (CA): Academic Press, p. 296.
74. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsi-malova S, Aldrich M, Reynolds D, Albin R et al. 2000. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 6:991-997.
75. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sut-cliffe JG, Kilduff TS. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 18:9996-10015.
76. Porter JT, Cauli B, Tsuzuki K, Lambolez B, Rossier J, Audinat E. 1999.Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J Neurosci. 19:5228-5235.
77. Richardson KA, Fanselow EE, Connors BW, 2007. Neocortical anatomy and physiology. In: Engel J Jr, Pedley TA, editors. Epilepsy: a comprehensive textbook. 2nd ed. Philadelphia (PA): Lippincott Williams and Wilkins. p. 323-335.
78. Rieger M, Mayer G, Gauggel S. 2003. Attention deficits in patients with narcolepsy. Sleep. 26:36-43.
79. Rudy B, Fishell G, Lee S, Hjerling-Leffler J. 2011. Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Dev Neurobiol. 71:45-61.
80. Sakurai T. 2007. The neural circuit of orexin (hypocretin): maintaining sleep and 'wakefulness. Nat Rev Neurosci. 8:171-181.
81. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, Wilson S et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour. Cell. 92:573-585.
82. Schone C, Cao ZF, Apergis-Schoute J, Adamantidis A, Sakurai T, Burda-kov D. 2012. Optogenetic probing of fast glutamatergic transmission from hypocretin/orexin to histamine neurons in situ. J Neurosci. 32:12437-12443.
83. Smart D, Jerman JC, Brough SJ, Rushton SL, Murdock PR, Jewitt F, El-shourbagy NA, Ellis CE, Middlemiss DN, Brown F. 1999. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol. 128:1-3.
84. Smart D, Sabido-David C, Brough SJ, Jewitt F, Johns A, Porter RA, Jerman JC. 2001. SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol. 132:1179-1182.
85. Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. 2006. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev. 58:46-57.
86. Sutcliffe JG, de Lecea L. 2002. The hypocretins: setting the arousal threshold. Nat Rev Neurosci. 3:339-349.
87. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 27:469-474.
88. Trantham-Davidson H, Kroner S, Seamans JK. 2008. Dopamine modulation of prefrontal cortex interneurons occurs independently of DARPP-32. Cereb Cortex. 18:951-958.
89. Uylings HB, Groenewegen HJ, Kolb B. 2003. Do rats have a prefrontal cortex? Behav Brain Res. 146:3-17.
90. Van de Werd HJ, Rajkowska G, Evers P, Uylings HB. 2010. Cytoarchi-tectonic and chemoarchitectonic characterization of the prefrontal cortical areas in the mouse. Brain Struct Funct. 214:339-353.
91. Vittoz NM, Berridge CW. 2006. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology. 31:384-395.
92. Xia J, Chen X, Song C, Ye J, Yu Z, Hu Z. 2005. Postsynaptic excitation of prefrontal cortical pyramidal neurons by hypocretin-1/orexin A through the inhibition of potassium currents. J Neurosci Res. 82:729-736.
93. Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, To-minaga M, Yagami KI, Sugiyama F, Goto K et al. 2003. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 38:701-713.
94. Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan JL, Wang QP, Tominaga M, Goto K, Shioda S, Sakurai T. 2002. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun. 290:1237-1245.